Bankole A. Johnson, DSc, MD, MPhil, FRCPsych (born 5 November 1959) is a licensed physician and board-certified psychiatrist throughout Europe and the United States who served as Alumni Professor and Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia. Johnson's primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid (GABA) facilitator and glutamate antagonist, is an effective treatment for alcoholism.[1][2] Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, "Addiction", which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences.[3] Professor Johnson recently accepted an appointment to join the University of Maryland as the Chairman of Psychiatry and to lead a Brain Science Research Consortium in the neurosciences.
Johnson was born on 5 November 1959 in Nigeria. Johnson attended King's College in Lagos, Nigeria and received his diploma in 1975. He then went on to Davies' College in Sussex, England followed by the Institute Catholique de Paris in Paris, France. Johnson graduated from the University of Glasgow in Scotland in 1982 with a Medicinae Baccalaureum et Chirurgie Baccalaureum degree. He went on to train in psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals, and to train in research at the Institute of Psychiatry (University of London). In 1991, Johnson graduated from the University of London with a Master of Philosophy degree in neuropsychiatry. Johnson conducted his doctoral research at Oxford University and obtained a doctorate degree in medicine, Medicinae Doctorem, from the University of Glasgow in 1993. Most recently, in 2004, Johnson earned his Doctor of Science degree in medicine from the University of Glasgow – the highest degree that can be granted in science by a British university.
Johnson joined the faculty at the University of Texas Health Science Center in Houston in 1993 and later became the Deputy chairman for Research and Chief of the Division of Alcohol and Drug Addiction in the Department of Psychiatry at the University of Texas Health Science Center in San Antonio in 1998. In 2001, Johnson received the Dan Anderson Research Award from the Hazelden Foundation for his "distinguished contribution as a researcher who has advanced the scientific knowledge of addiction recovery."[4] In 2002, Johnson received the Distinguished Senior Scholar of Distinction Award from the National Medical Association. Johnson was inducted into the Texas Hall of Fame in 2003 for his contributions to science, mathematics, and technology.[5] On 1 September 2004, Johnson accepted an appointment to serve as Alumni Professor and Chairman of the Department of Psychiatric Medicine at the University of Virginia.[6] Johnson became a fellow of the Royal College of Psychiatrists in 2007. In 2009 Johnson was named associate editor of the editorial board of The American Journal of Psychiatry, and from 2010 to 2011 he served as field editor-in-chief of Frontiers in Psychiatry.
In 2019, Johnson received the R. Brinkley Smithers award from the American Association of Addiction Medicine.[7]
ResearchEdit
Johnson's research focus is on the neuropsychopharmacology of addiction. His work integrates the neuroscience and behavioural aspects of addiction medicine with the goal of formulating a more thorough understanding of the basis of drug-seeking behaviour and developing effective treatments. Central to his research is the role of and interaction between midbrain monoamine systems with a focus on serotonin, gamma-aminobutyric acid (GABA)/glutamate and dopamine.
Johnson's Journal of the American Medical Association (JAMA) paper, titled "Topiramate for treating alcohol dependence: a randomized controlled trial" and published in 2007, gained national and international media attention. The 14-week US multi-site clinical trial involved 371 male and female alcoholics. Those patients taking topiramate had reduced heavy drinking and showed better results with lowering cholesterol, body mass index, liver enzymes, and blood pressure than those taking the placebo.[8] The study results were featured on Reuters, MSNBC, CBS, ABC, CNN, Fox News, USA Today, the Associated Press, and many other media outlets.[9][10][11][12][13][14]
Johnson’s current research involves clinical trials and human laboratory studies, and includes neuroimaging and molecular genetics. He now incorporates neuroimaging evaluations into his drug interaction studies to identify the site-specific effects of abused drugs and to evaluate the effectiveness of potential medications for the treatment of addiction. Current studies include a clinical trial aimed at determining the effectiveness of ondansetron, a serotonin-3 antagonist, for the treatment of subtypes of alcoholics, as well as a human laboratory project trying to elucidate the effects of naltrexone and acamprosate on hepatic and renal function in alcohol-dependent individuals.
Honors and awardsEdit
Inductee, Texas Hall of Fame for Science, Mathematics and Technology, 2003
Appointed to the National Advisory Council for NIH/NIDA, 2004 – 2007
Member, Medications Development Subcommittee of NIDA's Advisory Council on Drug Abuse, 2004 – 2007
Member, Extramural Advisory Board for NIH/NIAAA, 2004 – present
Member, Medications Development Scientific Advisory Board for NIH/NIDA, 2005 – 2009
American Psychiatric Association Distinguished Psychiatrist Lecturer Award, 2006 (for outstanding achievement in the field of psychiatry as an educator, researcher, and clinician)
NIH Roadmap Consultant, 2006 – present
Listed in "Best Doctors in America", 2007, 2009–2010
Fellow, Royal College of Psychiatrists, 2007 – present
Distinguished Fellow, American Psychiatric Association, 2008 – present
American Psychiatric Association, Solomon Carter Fuller Award, 2009
Fellow, American College of Neuropsychopharmacology, 2010 – present
^Johnson BA, Ait-Daoud N, Bowden CL, et al. 2003. Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 361, 1677–1685
^"Dr. Bankole Johnson, new chairman of Psychiatric Medicine". 2004. . Archived from the original on 24 July 2008. Retrieved 2008-11-10.
^"Dr. Bankole Johnson ( Miami/Fort Lauderdale )". Haute Living. Retrieved 28 September 2020.
^Johnson BA, Rosenthal N, Capece JA, et al. 2008. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Archives of Internal Medicine. 168: 1188–1199.
^"A Pill to Cure Alcoholism?". Retrieved 22 June 2023.
^"Migraine Drug May Treat Alcoholism, Too". ABC News. Retrieved 22 June 2023.
^"Migraine pill helps curb drinking without detox: New approach called promising, but side effects still a problem, study finds" 9 October 2007. http://www.nbcnews.com/id/21209314
bankole, johnson, bankole, johnson, mphil, frcpsych, born, november, 1959, licensed, physician, board, certified, psychiatrist, throughout, europe, united, states, served, alumni, professor, chairman, department, psychiatry, neurobehavioral, sciences, universi. Bankole A Johnson DSc MD MPhil FRCPsych born 5 November 1959 is a licensed physician and board certified psychiatrist throughout Europe and the United States who served as Alumni Professor and Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia Johnson s primary area of research expertise is the psychopharmacology of medications for treating addictions and he is well known in the field for his discovery that topiramate a gamma aminobutyric acid GABA facilitator and glutamate antagonist is an effective treatment for alcoholism 1 2 Professor Johnson also received national media attention for his appearance in the Home Box Office HBO original documentary feature Addiction which won the prestigious Governors Award a special Emmy Award from the Academy of Television Arts and Sciences 3 Professor Johnson recently accepted an appointment to join the University of Maryland as the Chairman of Psychiatry and to lead a Brain Science Research Consortium in the neurosciences Contents 1 Biography 2 Research 3 Honors and awards 4 References 5 External linksBiography EditJohnson was born on 5 November 1959 in Nigeria Johnson attended King s College in Lagos Nigeria and received his diploma in 1975 He then went on to Davies College in Sussex England followed by the Institute Catholique de Paris in Paris France Johnson graduated from the University of Glasgow in Scotland in 1982 with a Medicinae Baccalaureum et Chirurgie Baccalaureum degree He went on to train in psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals and to train in research at the Institute of Psychiatry University of London In 1991 Johnson graduated from the University of London with a Master of Philosophy degree in neuropsychiatry Johnson conducted his doctoral research at Oxford University and obtained a doctorate degree in medicine Medicinae Doctorem from the University of Glasgow in 1993 Most recently in 2004 Johnson earned his Doctor of Science degree in medicine from the University of Glasgow the highest degree that can be granted in science by a British university Johnson joined the faculty at the University of Texas Health Science Center in Houston in 1993 and later became the Deputy chairman for Research and Chief of the Division of Alcohol and Drug Addiction in the Department of Psychiatry at the University of Texas Health Science Center in San Antonio in 1998 In 2001 Johnson received the Dan Anderson Research Award from the Hazelden Foundation for his distinguished contribution as a researcher who has advanced the scientific knowledge of addiction recovery 4 In 2002 Johnson received the Distinguished Senior Scholar of Distinction Award from the National Medical Association Johnson was inducted into the Texas Hall of Fame in 2003 for his contributions to science mathematics and technology 5 On 1 September 2004 Johnson accepted an appointment to serve as Alumni Professor and Chairman of the Department of Psychiatric Medicine at the University of Virginia 6 Johnson became a fellow of the Royal College of Psychiatrists in 2007 In 2009 Johnson was named associate editor of the editorial board of The American Journal of Psychiatry and from 2010 to 2011 he served as field editor in chief of Frontiers in Psychiatry In 2019 Johnson received the R Brinkley Smithers award from the American Association of Addiction Medicine 7 Research EditJohnson s research focus is on the neuropsychopharmacology of addiction His work integrates the neuroscience and behavioural aspects of addiction medicine with the goal of formulating a more thorough understanding of the basis of drug seeking behaviour and developing effective treatments Central to his research is the role of and interaction between midbrain monoamine systems with a focus on serotonin gamma aminobutyric acid GABA glutamate and dopamine Johnson s Journal of the American Medical Association JAMA paper titled Topiramate for treating alcohol dependence a randomized controlled trial and published in 2007 gained national and international media attention The 14 week US multi site clinical trial involved 371 male and female alcoholics Those patients taking topiramate had reduced heavy drinking and showed better results with lowering cholesterol body mass index liver enzymes and blood pressure than those taking the placebo 8 The study results were featured on Reuters MSNBC CBS ABC CNN Fox News USA Today the Associated Press and many other media outlets 9 10 11 12 13 14 Johnson s current research involves clinical trials and human laboratory studies and includes neuroimaging and molecular genetics He now incorporates neuroimaging evaluations into his drug interaction studies to identify the site specific effects of abused drugs and to evaluate the effectiveness of potential medications for the treatment of addiction Current studies include a clinical trial aimed at determining the effectiveness of ondansetron a serotonin 3 antagonist for the treatment of subtypes of alcoholics as well as a human laboratory project trying to elucidate the effects of naltrexone and acamprosate on hepatic and renal function in alcohol dependent individuals Honors and awards EditInductee Texas Hall of Fame for Science Mathematics and Technology 2003 Appointed to the National Advisory Council for NIH NIDA 2004 2007 Member Medications Development Subcommittee of NIDA s Advisory Council on Drug Abuse 2004 2007 Member Extramural Advisory Board for NIH NIAAA 2004 present Member Medications Development Scientific Advisory Board for NIH NIDA 2005 2009 American Psychiatric Association Distinguished Psychiatrist Lecturer Award 2006 for outstanding achievement in the field of psychiatry as an educator researcher and clinician NIH Roadmap Consultant 2006 present Listed in Best Doctors in America 2007 2009 2010 Fellow Royal College of Psychiatrists 2007 present Distinguished Fellow American Psychiatric Association 2008 present American Psychiatric Association Solomon Carter Fuller Award 2009 Fellow American College of Neuropsychopharmacology 2010 present Jack Mendelson Award NIAAA 2013References Edit www healthsystem virginia edu internet psychiatric staffandfaculty research cfm uva id bj4x amp hideintro 1 Johnson BA Ait Daoud N Bowden CL et al 2003 Oral topiramate for treatment of alcohol dependence A randomised controlled trial Lancet 361 1677 1685 NIH received two emmy awards for the addiction project 16 September 2007 http www medicalnewstoday com articles 82613 php www hbo com addiction thefilm bios 6423 Bankole Johnson html Drs Bankole Johnson Wen Hwa Lee join luminaries in Texas Hall of Fame February 2003 http www uthscsa edu mission article asp id 123 Dr Bankole Johnson new chairman of Psychiatric Medicine 2004 Dr Bankole Johnson new chairman of psychiatric medicine 09 03 2004 Archived from the original on 24 July 2008 Retrieved 2008 11 10 Dr Bankole Johnson Miami Fort Lauderdale Haute Living Retrieved 28 September 2020 Johnson BA Rosenthal N Capece JA et al 2008 Improvement of physical health and quality of life of alcohol dependent individuals with topiramate treatment US multisite randomized controlled trial Archives of Internal Medicine 168 1188 1199 A Pill to Cure Alcoholism Retrieved 22 June 2023 Topiramate may help treat alcohol dependence 10 October 2007 http www medicalnewstoday com printerfriendlynews php newsid 85202 Study Migraine pill helps some alcoholics taper off 9 October 2007 Study Migraine pill helps some alcoholics taper off CNN com CNN Archived from the original on 19 December 2008 Retrieved 2008 11 10 Pill helps alcoholics taper off drinking 9 October 2007 http www foxnews com printer friendly wires 2007Oct09 0 4675 AlcoholismPill 00 html Migraine Drug May Treat Alcoholism Too ABC News Retrieved 22 June 2023 Migraine pill helps curb drinking without detox New approach called promising but side effects still a problem study finds 9 October 2007 http www nbcnews com id 21209314External links EditUniversity of Virginia http www healthsystem virginia edu internet psychiatric staffandfaculty research cfm uva id bj4x amp hideintro 1 The Excelsior Program http www medicine virginia edu clinical departments psychiatry patients excelsior HBO Addiction Film Series Addiction http www hbo com addiction thefilm centerpiece 618 segment 7 html Frontiers in Psychiatry https web archive org web 20100211141806 http frontiersin org psychiatry psychiatry missionstatement University of Maryland https web archive org web 20151001110541 http somvweb som umaryland edu absolutenm templates a 2446 amp z 41 Retrieved from https en wikipedia org w index php title Bankole Johnson amp oldid 1161378667, wikipedia, wiki, book, books, library,
